Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:54 PM
Ignite Modification Date:
2025-12-24 @ 5:54 PM
NCT ID:
NCT02411968
Eligibility Criteria:
Inclusion Criteria:
* \>50 years of age;
* At least one untreated T1a tumour of one kidney (tumour ≤ 4 cm in greatest dimension);
* Signed IRB-approved informed consent form.
Exclusion Criteria:
* Pregnancy or breast feeding;
* Known hypersensitivity or HACA against Girentuximab.
* Administration of experimental medication for imaging purposes within three months before administration of Indium-111-Girentuximab for this study, except the administration of Girentuximab labeled with a random isotope.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Study:
NCT02411968
Study Brief:
Protocol Section:
NCT02411968